Envveno Medical Corp Stock Analysis

NVNO Stock  USD 5.18  0.05  0.96%   
enVVeno Medical Corp is undervalued with Real Value of 8.8 and Target Price of 20.4. The main objective of EnVVeno Medical stock analysis is to determine its intrinsic value, which is an estimate of what enVVeno Medical Corp is worth, separate from its market price. There are two main types of EnVVeno Medical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect EnVVeno Medical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of EnVVeno Medical's stock to identify patterns and trends that may indicate its future price movements.
The EnVVeno Medical stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. EnVVeno Medical is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. EnVVeno Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and EnVVeno Medical's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

EnVVeno Stock Analysis Notes

About 35.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.44. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. enVVeno Medical Corp recorded a loss per share of 1.91. The entity last dividend was issued on the 30th of November 2020. The firm had 1:25 split on the 30th of November 2020. enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California. Envveno Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 24 people. To find out more about enVVeno Medical Corp contact Robert Berman at 949 261 2900 or learn more at https://www.envveno.com.

enVVeno Medical Corp Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. EnVVeno Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding enVVeno Medical Corp or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
enVVeno Medical Corp had very high historical volatility over the last 90 days
Net Loss for the year was (23.52 M) with profit before overhead, payroll, taxes, and interest of 0.
enVVeno Medical Corp currently holds about 37.48 M in cash with (18.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.96.
enVVeno Medical Corp has a poor financial position based on the latest SEC disclosures
Latest headline from finance.yahoo.com: Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medicals VenoValve Pivotal Trial to be Presented Today at the 46th Annual Charing Cross Symposium

enVVeno Medical Corp Upcoming and Recent Events

Earnings reports are used by EnVVeno Medical to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to EnVVeno Medical previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
25th of January 2024
Upcoming Quarterly Report
View
6th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
25th of January 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

EnVVeno Largest EPS Surprises

Earnings surprises can significantly impact EnVVeno Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2019-08-05
2019-06-30-0.11-0.13-0.0218 
2021-08-11
2021-06-30-0.34-0.280.0617 
2021-11-12
2021-09-30-0.34-0.260.0823 
View All Earnings Estimates

EnVVeno Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as EnVVeno Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading enVVeno Medical Corp backward and forwards among themselves. EnVVeno Medical's institutional investor refers to the entity that pools money to purchase EnVVeno Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Blackrock Inc2023-12-31
38.1 K
Northern Trust Corp2023-12-31
37.5 K
State Street Corporation2023-12-31
26.6 K
Fermata Advisors, Llc2024-03-31
23.2 K
Susquehanna International Group, Llp2023-12-31
18.7 K
Dimensional Fund Advisors, Inc.2023-12-31
18.3 K
Marshall Wace Asset Management Ltd2023-12-31
15.3 K
Arthur M. Cohen & Associates Llc2023-12-31
14 K
Tamar Securities, Llc2023-12-31
14 K
Nantahala Capital Management, Llc2023-12-31
1.4 M
Kingdon Capital Management Llc2023-12-31
838.4 K
Note, although EnVVeno Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

EnVVeno Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 69.65 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate EnVVeno Medical's market, we take the total number of its shares issued and multiply it by EnVVeno Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

EnVVeno Profitablity

EnVVeno Medical's profitability indicators refer to fundamental financial ratios that showcase EnVVeno Medical's ability to generate income relative to its revenue or operating costs. If, let's say, EnVVeno Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, EnVVeno Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of EnVVeno Medical's profitability requires more research than a typical breakdown of EnVVeno Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.48)(0.51)
Return On Capital Employed(0.53)(0.51)
Return On Assets(0.48)(0.51)
Return On Equity(0.51)(0.53)

Management Efficiency

enVVeno Medical Corp has return on total asset (ROA) of (0.3494) % which means that it has lost $0.3494 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5538) %, meaning that it created substantial loss on money invested by shareholders. EnVVeno Medical's management efficiency ratios could be used to measure how well EnVVeno Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of the 26th of April 2024, Return On Tangible Assets is likely to drop to -0.51. In addition to that, Return On Capital Employed is likely to grow to -0.51. At this time, EnVVeno Medical's Total Assets are very stable compared to the past year. As of the 26th of April 2024, Non Current Assets Total is likely to grow to about 1.8 M, while Non Currrent Assets Other are likely to drop about 29.4 K.
Last ReportedProjected for Next Year
Book Value Per Share 3.76  3.94 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share 3.76  3.94 
Enterprise Value Over EBITDA(2.47)(2.59)
Price Book Value Ratio 1.37  1.44 
Enterprise Value Multiple(2.47)(2.59)
Price Fair Value 1.37  1.44 
Enterprise Value61 M64.1 M
The analysis of EnVVeno Medical's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze EnVVeno Medical's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of EnVVeno Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
1.116

Technical Drivers

As of the 26th of April, EnVVeno Medical shows the semi deviation of 3.61, and Risk Adjusted Performance of 0.0661. In respect to fundamental indicators, the technical analysis model provides you with a way to check existing technical drivers of EnVVeno Medical, as well as the relationship between them. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate nineteen technical drivers for enVVeno Medical Corp, which can be compared to its peers. Please confirm enVVeno Medical Corp jensen alpha and downside variance to decide if enVVeno Medical Corp is priced favorably, providing market reflects its regular price of 5.18 per share. Given that EnVVeno Medical has jensen alpha of 0.4489, we urge you to verify enVVeno Medical Corp's prevailing market performance to make sure the company can sustain itself at a future point.

enVVeno Medical Corp Price Movement Analysis

null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. EnVVeno Medical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for enVVeno Medical Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

enVVeno Medical Corp Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific EnVVeno Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on EnVVeno Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases EnVVeno Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

EnVVeno Medical Predictive Daily Indicators

EnVVeno Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of EnVVeno Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

EnVVeno Medical Corporate Filings

8K
24th of April 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
15th of March 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
6th of March 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
10K
29th of February 2024
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
13A
23rd of February 2024
An amended filing to the original Schedule 13G
ViewVerify
13A
14th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
8K
7th of December 2023
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
16th of November 2023
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify

EnVVeno Medical Forecast Models

EnVVeno Medical's time-series forecasting models are one of many EnVVeno Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary EnVVeno Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About EnVVeno Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how EnVVeno Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling EnVVeno shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as EnVVeno Medical. By using and applying EnVVeno Stock analysis, traders can create a robust methodology for identifying EnVVeno entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(280.68)(266.64)
Operating Profit Margin(282.51)(268.39)
Net Loss(280.68)(266.64)
Gross Profit Margin 0.01  0.01 

Current EnVVeno Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. EnVVeno analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. EnVVeno analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
20.4Strong Buy1Odds
enVVeno Medical Corp current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most EnVVeno analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand EnVVeno stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of enVVeno Medical Corp, talking to its executives and customers, or listening to EnVVeno conference calls.
EnVVeno Analyst Advice Details

EnVVeno Stock Analysis Indicators

enVVeno Medical Corp stock analysis indicators help investors evaluate how EnVVeno Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading EnVVeno Medical shares will generate the highest return on investment. By understating and applying EnVVeno Medical stock analysis, traders can identify EnVVeno Medical position entry and exit signals to maximize returns.
Begin Period Cash Flow4.6 M
Common Stock Shares Outstanding12.3 M
Total Stockholder Equity46.2 M
Property Plant And Equipment Net1.7 M
Cash And Short Term Investments46.4 M
Cash3.6 M
Accounts Payable427 K
Net Debt-2.2 M
50 Day M A5.5374
Total Current Liabilities1.4 M
Other Operating Expenses25.2 M
Non Current Assets Total1.7 M
Non Currrent Assets Other31 K
Stock Based Compensation5.2 M
When determining whether enVVeno Medical Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EnVVeno Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Envveno Medical Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Envveno Medical Corp Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for EnVVeno Stock analysis

When running EnVVeno Medical's price analysis, check to measure EnVVeno Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EnVVeno Medical is operating at the current time. Most of EnVVeno Medical's value examination focuses on studying past and present price action to predict the probability of EnVVeno Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EnVVeno Medical's price. Additionally, you may evaluate how the addition of EnVVeno Medical to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Is EnVVeno Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.91)
Return On Assets
(0.35)
Return On Equity
(0.55)
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.